Reply Memorandum Of Law In Support Of: WHISTLEBLOWERS & RESEARCH, v. NATIONAL INSTITUTES OF HEALTH,
Summary
Reply Memorandum of Law, Document 25, filed 04/06/22 in the Eastern District of Virginia, Alexandria Division (Case No. 1:21-cv-1275), in Empower Oversight Whistleblowers & Research v. National Institutes of Health. The memorandum supports NIH's Motion to Vacate the Scheduling Order in a Freedom of Information Act (FOIA) case. NIH argues that Plaintiff has not shown it is entitled to pre-summary judgment discovery, that discovery in FOIA cases is the exception rather than the rule, and that Plaintiff has not alleged bad faith. NIH states that it provided the declaration of its FOIA Officer to Plaintiff on March 25, 2022, and that supplemental declarations can address any defects.
Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used
Cite this document
“Reply Memorandum Of Law In Support Of: WHISTLEBLOWERS & RESEARCH, v. NATIONAL INSTITUTES OF HEALTH,.”
Original at archive.org. Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/gov-uscourts-vaed-516270-25-0-05da33b412/
, SHA-256 73f4a7ec89fff6c8eac658361691a5a7169614fa92ea6a087cd798f28b285a47.Full text
Case 1:21-cv-01275-LMB-JFA Document 25 Filed 04/06/22 Page 1 of 4 PageID# 329
IN THE UNITED STATES DISTRICT COURT
FOR THE EASTERN DISTRICT OF VIRGINIA
Alexandria Division
EMPOWER OVERSIGHT )
WHISTLEBLOWERS & RESEARCH, )
)
Plaintiff, )
) Case No. 1:21-cv-1275 (LMB/JFA)
v. )
)
NATIONAL INSTITUTES OF HEALTH, )
)
Defendant. )
)
)
REPLY MEMORANDUM OF LAW IN SUPPORT OF
NATIONAL INSTITUTES OF HEALTH’S MOTION TO VACATE
Plaintiff’s Opposition to National Institutes of Health’s (“NIH”) Motion to Vacate the
Scheduling Order fails to demonstrate that it is entitled to pre-summary judgment discovery in
this Freedom of Information Act (“FOIA”) case. Well-settled case law establishes that discovery
in FOIA cases is the exception rather than the rule. And in the rare cases where discovery is
appropriate—typically upon a plaintiff’s showing of bad faith by the government, which Plaintiff
has not alleged here (and, indeed, could not) —Plaintiff admits on the first page of its Opposition
that such discovery is appropriate only after the Court has had an opportunity to review the
government’s motion for summary judgment. Opp’n (Dkt. 24) at 1. This Court should reject
Plaintiff’s invitation to overturn precedent regarding the propriety of discovery in FOIA cases,
especially where, as here, Plaintiff has put forward no compelling reason for such a sea change.
Before delving into the merits of Plaintiff’s Opposition, it is important to understand the
context in which NIH provided the declaration of Gorka Garcia-Malene, NIH’s FOIA Officer, to
Plaintiff. Aware that FOIA cases “should be resolved on summary judgment,” Hanson v. U.S.
1
Case 1:21-cv-01275-LMB-JFA Document 25 Filed 04/06/22 Page 2 of 4 PageID# 330
Agency for Int’l Dev., 372 F.3d 286, 290 (4th Cir. 2004), counsel for NIH asked opposing
counsel to meet and confer on a briefing schedule for cross-motions for summary judgment that
could be filed simultaneously with NIH’s Answer. See Def.’s Br. (Dkt. 20) at 2. Plaintiff
resisted setting a briefing schedule. Instead, Plaintiff suggested that NIH preview the declaration
it intended to use in support of its motion for summary judgment in an effort to either resolve the
case without such briefing or to narrow the issues to brief. Id. NIH’s understanding was that
Plaintiff would review the declaration and either bring to NIH’s attention additional issues that
the parties could then negotiate and resolve, or that Plaintiff would be satisfied that NIH had
made a good-faith effort to undertake a search reasonably calculated to yield responsive
documents and dismiss the case. 1 NIH provided the declaration to Plaintiff on March 25, 2022.
The only communication NIH has received from Plaintiff regarding the declaration since that
date is the notice of electronic filing alerting NIH that Plaintiff had attached the declaration to its
Opposition to NIH’s Motion to Vacate the Scheduling Order.
Turning to the merits of that Opposition, Plaintiff concedes that “discovery in FOIA
cases typically occurs only after the Government files a motion for summary judgment.” Opp’n
(Dkt. 24) at 1 (citing Williams Mullen v. U.S. Army Criminal Investigation Command, 2011 WL
5870550, at *3 (E.D. Va. Nov. 22, 2011)). Nonetheless, Plaintiff argues that the “facts and
current procedural posture of this case” require immediate discovery before any summary
judgment briefs have been filed. Id. at 2.
There is nothing unusual about this FOIA case that would merit discovery, let alone
discovery before NIH has filed its motion for summary judgment. “Discovery in FOIA cases is
1
NIH’s proposed briefing schedule accounts for this process, proposing that opening briefs be
filed on or before May 13, 2022. (Dkt. 19-1).
2
Case 1:21-cv-01275-LMB-JFA Document 25 Filed 04/06/22 Page 3 of 4 PageID# 331
rare,” Cole v. Copan, 485 F. Supp. 3d 243, 249 (D.D.C. 2020), and is generally not appropriate
“prior to the government filing a motion for summary judgment explaining the appropriateness
of its decision,” Williams Mullen, 2011 WL 5870550, at *3. The government establishes the
“appropriateness of its decision” through agency affidavits or declarations explaining the search.
Cole, 485 F. Supp. 3d at 249. The court then evaluates those affidavits, which are “entitled to a
presumption of good faith,” and “a court may grant summary judgment based on an affidavit it if
contains reasonably specific detail and neither contradictory record evidence nor evidence of bad
faith calls it into question.” Id. When the court believes an affidavit lacks sufficient detail,
discovery is almost never the answer. “When an agency’s declarations are insufficient to
establish an adequate search, courts generally will request that an agency supplement its
supporting declarations instead of ordering discovery.” Cole, 485 F. Supp. 3d at 254 (citations
and internal quotation marks omitted). “Limited discovery is typically only permitted when the
agency has acted in bad faith, such as in cases where there has been extreme delay or evidence of
wrongdoing.” Id. (emphasis added).
Plaintiff has made no such allegations of bad faith or extreme delay here. And, as
Plaintiff admits, even in the rare circumstances where discovery is appropriate, it is not permitted
until after the Court has had an opportunity to review the agency’s summary judgment briefing
and supporting exhibits. Opp’n at 1. Rather than explain why “the facts and current procedural
posture of this case” warrant deviating from the well-accepted rule that discovery is not needed
in FOIA cases, Plaintiff’s Opposition attempts to argue that discovery is needed now to
determine the ultimate question in this case—that is, whether NIH’s FOIA search was reasonably
calculated to produce responsive records. In other words, “what Plaintiff is asking for is
discovery to evaluate what he believes to be the insufficiency of the government’s response to
3
Case 1:21-cv-01275-LMB-JFA Document 25 Filed 04/06/22 Page 4 of 4 PageID# 332
his FOIA request and the improper withholding of information under FOIA exemptions.”
Thompson v. United States, 2010 WL 231782, at *3 (E.D. Va. Jan. 19, 2010). But these are
questions of law that the Court can “properly evaluate” after NIH has filed is summary judgment
motion. Id.
Furthermore, Plaintiff’s Opposition prematurely attempts to argue the adequacy of NIH’s
search, which is clearly inappropriate given the procedural posture of this case. There is no bar
on NIH providing additional evidence at summary judgment to address the concerns that
Plaintiff raises in its Opposition. Thus, the remedy to the purported defects in NIH’s declaration
is not carte blanche discovery, but rather supplemental declarations, which NIH can (and will)
provide in the context of its summary judgment briefing. Cole, 485 F. Supp. 3d at 254.
Plaintiff has failed to make a convincing arugment on why it is entitled to discovery now,
before the Court has considered the parties’ summary judgment briefs and where there are no
allegations of bad faith. This Court should grant NIH’s motion, vacate the scheduling order, and
enter the briefing schedule proposed by NIH.
Dated: April 6, 2022 Respectfully submitted,
JESSICA D. ABER
UNITED STATES ATTORNEY
By: /s/
MEGHAN LOFTUS
Assistant United States Attorney
Office of the United States Attorney
Justin W. Williams U.S. Attorney’s Building
2100 Jamieson Ave.
Alexandria, VA 22314
Tel: (703) 299-3757
Fax: (703) 299-3983
Email: meghan.loftus@usdoj.gov
Counsel for Defendant
4File and source
- File
- gov.uscourts.vaed.516270.25.0.pdf
- Size
- 167,140 bytes
- SHA-256
- 73f4a7ec89fff6c8eac658361691a5a7169614fa92ea6a087cd798f28b285a47
- Original
- archive.org